[Evaluation of cephalexin monohydrate in patients with uncomplicated urinary infections].
D002511:Cephalosporins / Q000009:adverse effects / Q000627:therapeutic use*; D004756:Enterobacteriaceae Infections / Q000188:drug therapy*; D004927:Escherichia coli Infections / Q000188:drug therapy; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007676:Kidney Failure, Chronic / Q000209:etiology; D007710:Klebsiella Infections / Q000188:drug therapy; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011512:Proteus Infections / Q000188:drug therapy; D011645:Puerperal Infection / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy*
D002511:Cephalosporins
Evaluación del monohidrato de cefalexina en pacientes con infecciones urinarias no complicadas.